NMTC director receives stock options and RSUs
NEUROONE MEDICAL TECHNOLOGIES Corp director Jason Richard Mills reported equity compensation awards.
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
NEUROONE MEDICAL TECHNOLOGIES Corp director Jason Richard Mills reported equity compensation awards. He received options to purchase 26,036 shares of common stock at an exercise price of $0.795 per share, expiring on April 2, 2036, vesting in 12 equal monthly installments.
He also received a grant of 41,929 restricted stock units that vest in 12 equal monthly installments over one year, with vesting at the end of each month. Following the stock grant, he holds 49,687 shares of common stock directly.
Insider Trade Summary
Grant/Award: 67,965 shares
Grant/Award
2 txns
Insider
Mills Jason Richard
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Option to Purchase Common Stock | 26,036 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 41,929 | $0.00 | $0.00 |
Holdings After Transaction:
Option to Purchase Common Stock — 26,036 contracts (Direct);
Common Stock — 49,687 shares (Direct)
Footnotes (2)
- F1. Represents a grant of restricted stock units, which vest in 12 equal monthly installments over a one-year period, with such vesting to occur at the end of each month.
- F2. The option vests in 12 equal monthly installments over a one-year period, with such vesting to occur at the end of each month.
Key Figures
Option grant size: 26,036 options
Option exercise price: $0.795 per share
Option expiration: April 2, 2036
+2 more
5 metrics
Option grant size
26,036 options
Director option award on April 3, 2026
Option exercise price
$0.795 per share
Exercise price for director options
Option expiration
April 2, 2036
Expiration date of granted options
RSU grant size
41,929 RSUs
Restricted stock units vesting over one year
Shares held after grant
49,687 shares
Common stock directly owned after award
Key Terms
restricted stock units, exercise price, vesting, expiration date
4 terms
restricted stock units financial
"Represents a grant of restricted stock units, which vest in 12 equal monthly installments"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
exercise price financial
"He received options to purchase 26,036 shares ... at an exercise price of $0.795 per share"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"vest in 12 equal monthly installments over a one-year period, with such vesting to occur"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
expiration date financial
"expiring on April 2, 2036, vesting in 12 equal monthly installments"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did NMTC director Jason Mills report on this Form 4?
Jason Mills reported equity compensation awards, including stock options and restricted stock units. These are grants from NEUROONE MEDICAL TECHNOLOGIES Corp, not open-market purchases, and reflect standard director compensation rather than discretionary buying or selling in the public market.
How many stock options did Jason Mills receive from NEUROONE MEDICAL TECHNOLOGIES (NMTC)?
Jason Mills received options to purchase 26,036 shares of NEUROONE common stock. These options have an exercise price of $0.795 per share and expire on April 2, 2036, providing long-term equity exposure if he chooses to exercise in the future.
What are the terms of the restricted stock units granted to NMTC director Jason Mills?
Jason Mills was granted 41,929 restricted stock units in NEUROONE MEDICAL TECHNOLOGIES. These RSUs vest in 12 equal monthly installments over one year, with each monthly tranche vesting at the end of the month, aligning his compensation with ongoing board service.
How do the stock options granted to NMTC’s Jason Mills vest over time?
The options granted to Jason Mills vest in 12 equal monthly installments over a one-year period. Vesting occurs at the end of each month, meaning his exercisable option balance increases gradually as each monthly installment becomes vested throughout the year.
Were Jason Mills’ NMTC transactions open-market buys or compensation grants?
The transactions were compensation grants, not open-market trades. Both the options and the 41,929 common shares are coded as acquisitions from grants or awards, with a reported price of $0.0000 per share, consistent with equity-based director compensation.
AI-generated analysis. How Rhea-AI works. Not financial advice.
